Human Peripheral Blood Leukocyte Extract: sc-363771

Human Peripheral Blood Leukocyte Extract (HPBLE) is derived from peripheral blood leukocytes, which are a vital component of the immune system. Leukocytes encompass various cell types, including lymphocytes, monocytes, neutrophils, eosinophils, and basophils, each contributing to immune responses through distinct mechanisms. HPBLE contains a diverse array of bioactive molecules, including cytokines, chemokines, growth factors, and immunomodulatory proteins, originating from leukocytes. These components play pivotal roles in regulating immune responses, inflammation, and host defense mechanisms. In research, HPBLE is extensively utilized to investigate immune cell functions, immune modulation, and inflammatory processes. Researchers employ HPBLE to stimulate immune cells in vitro, studying their activation, proliferation, cytokine production, and interactions with other cell types. Furthermore, HPBLE is employed in studies exploring the immunomodulatory effects of various compounds or interventions, assessing their impact on immune cell function and inflammation. Moreover, HPBLE is utilized in research related to autoimmune diseases, infectious diseases, cancer immunotherapy, and vaccine development, providing insights into immune responses and potential strategies. Overall, HPBLE serves as a valuable tool in immunological research, offering applications in studying immune cell biology, inflammation, and immune-mediated diseases.

Human Peripheral Blood Leukocyte Extract References:

1. Nonspecific protease and elastase activities in rat leukocytes.  |  Varani, J., et al. 1982. Inflammation. 6: 177-87. PMID: 7049937